Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

IκB-α Inhibitors

IκB-α inhibitors represent a diverse class of small molecules that have garnered significant attention in the realm of molecular biology and cellular signaling pathways. These inhibitors are primarily designed to modulate the activity of the inhibitor of nuclear factor-kappa B alpha (IκB-α) protein, a pivotal player in the regulation of the nuclear factor-kappa B (NF-κB) signaling pathway. NF-κB is a family of transcription factors that govern a myriad of cellular processes, including inflammation, immune response, and cell survival. IκB-α, on the other hand, functions as a natural brake on NF-κB activity by sequestering it in the cytoplasm. However, upon exposure to various stimuli such as proinflammatory cytokines, pathogens, or stress, IκB-α becomes phosphorylated and subsequently degraded, allowing NF-κB to translocate into the nucleus and activate a plethora of target genes. IκB-α inhibitors, by virtue of their distinctive mechanisms of action, aim to interfere with this process and restrain NF-κB's transcriptional activity.

The mechanisms by which IκB-α inhibitors achieve their inhibitory effects are multifaceted. Some compounds within this class directly target key enzymes involved in the phosphorylation and degradation of IκB-α, such as IκB kinases (IKKs), inhibiting their activity and preventing IκB-α phosphorylation. This, in turn, impedes the subsequent ubiquitination and proteasomal degradation of IκB-α. Others may act indirectly by stabilizing IκB-α, thus enhancing its ability to sequester NF-κB in the cytoplasm. Additionally, some IκB-α inhibitors may interfere with the nuclear translocation of NF-κB subunits. These diverse mechanisms collectively converge on the overarching goal of dampening NF-κB signaling, which can have profound implications for cellular responses to inflammation, immunity, and stress. While the practical applications of IκB-α inhibitors are vast and continue to be explored in the context of various diseases, their significance fundamentally lies in their capacity to unveil the intricacies of the NF-κB pathway and provide valuable insights into the regulation of gene expression and cellular behavior.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IKK Inhibitor X

431898-65-6sc-221742
5 mg
$345.00
3
(0)

PS-1145 is an IKK inhibitor that hinders the phosphorylation of IκB-α, thereby blocking NF-κB activation.

SC514

354812-17-2sc-205504
sc-205504A
5 mg
10 mg
$66.00
$89.00
13
(2)

SC-514 inhibits IKK-2, preventing IκB-α phosphorylation and subsequent NF-κB nuclear translocation.

Titanium(II) oxide

12137-20-1sc-251253
100 g
$244.00
(0)

TIO is an IKK inhibitor that targets IKKα/β and impedes IκB-α phosphorylation, thus blocking NF-κB activation.

NFκB Activation Inhibitor II, JSH-23

749886-87-1sc-222061
sc-222061C
sc-222061A
sc-222061B
5 mg
10 mg
50 mg
100 mg
$210.00
$252.00
$1740.00
$1964.00
34
(1)

JSH-23 inhibits nuclear translocation of p65 subunit of NF-κB by disrupting IκB-α degradation and phosphorylation.

QNZ

545380-34-5sc-200675
1 mg
$115.00
12
(1)

CAY-10470 selectively inhibits IKKα and IKKβ, blocking IκB-α phosphorylation and NF-κB activation.

NFκB Activation Inhibitor III

380623-76-7sc-204818
5 mg
$115.00
3
(1)

SM-7368 is an IKK-2 inhibitor that suppresses IκB-α phosphorylation, leading to inhibition of NF-κB activation.